These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21407267)

  • 1. Model-Based Multifactor Dimensionality Reduction to detect epistasis for quantitative traits in the presence of error-free and noisy data.
    Mahachie John JM; Van Lishout F; Van Steen K
    Eur J Hum Genet; 2011 Jun; 19(6):696-703. PubMed ID: 21407267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower-order effects adjustment in quantitative traits model-based multifactor dimensionality reduction.
    Mahachie John JM; Cattaert T; Lishout FV; Gusareva ES; Steen KV
    PLoS One; 2012; 7(1):e29594. PubMed ID: 22242176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model-based multifactor dimensionality reduction for detecting epistasis in case-control data in the presence of noise.
    Cattaert T; Calle ML; Dudek SM; Mahachie John JM; Van Lishout F; Urrea V; Ritchie MD; Van Steen K
    Ann Hum Genet; 2011 Jan; 75(1):78-89. PubMed ID: 21158747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity.
    Ritchie MD; Hahn LW; Moore JH
    Genet Epidemiol; 2003 Feb; 24(2):150-7. PubMed ID: 12548676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple and computationally efficient sampling approach to covariate adjustment for multifactor dimensionality reduction analysis of epistasis.
    Gui J; Andrew AS; Andrews P; Nelson HM; Kelsey KT; Karagas MR; Moore JH
    Hum Hered; 2010; 70(3):219-25. PubMed ID: 20924193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of internal model validation methods for multifactor dimensionality reduction in the case of genetic heterogeneity.
    Gory JJ; Sweeney HC; Reif DM; Motsinger-Reif AA
    BMC Res Notes; 2012 Nov; 5():623. PubMed ID: 23126544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epistasis analysis using multifactor dimensionality reduction.
    Moore JH; Andrews PC
    Methods Mol Biol; 2015; 1253():301-14. PubMed ID: 25403539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Belief Degree-Associated Fuzzy Multifactor Dimensionality Reduction Framework for Epistasis Detection.
    Rahaman S; Wong KC
    Methods Mol Biol; 2021; 2212():307-323. PubMed ID: 33733364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class Balanced Multifactor Dimensionality Reduction to Detect Gene-Gene Interactions.
    Yang CH; Lin YD; Chuang LY
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(1):71-81. PubMed ID: 30040653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An empirical fuzzy multifactor dimensionality reduction method for detecting gene-gene interactions.
    Leem S; Park T
    BMC Genomics; 2017 Mar; 18(Suppl 2):115. PubMed ID: 28361694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved fuzzy set-based multifactor dimensionality reduction for detecting epistasis.
    Yang CH; Chuang LY; Lin YD
    Artif Intell Med; 2020 Jan; 102():101768. PubMed ID: 31980105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariate dimensionality reduction approaches to identify gene-gene and gene-environment interactions underlying multiple complex traits.
    Xu HM; Sun XW; Qi T; Lin WY; Liu N; Lou XY
    PLoS One; 2014; 9(9):e108103. PubMed ID: 25259584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel survival multifactor dimensionality reduction method for detecting gene-gene interactions with application to bladder cancer prognosis.
    Gui J; Moore JH; Kelsey KT; Marsit CJ; Karagas MR; Andrew AS
    Hum Genet; 2011 Jan; 129(1):101-10. PubMed ID: 20981448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fuzzy set-based generalized multifactor dimensionality reduction analysis of gene-gene interactions.
    Jung HY; Leem S; Park T
    BMC Med Genomics; 2018 Apr; 11(Suppl 2):32. PubMed ID: 29697366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enabling personal genomics with an explicit test of epistasis.
    Greene CS; Himmelstein DS; Nelson HH; Kelsey KT; Williams SM; Andrew AS; Karagas MR; Moore JH
    Pac Symp Biocomput; 2010; ():327-36. PubMed ID: 19908385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized multifactor dimensionality reduction approaches to identification of genetic interactions underlying ordinal traits.
    Hou TT; Lin F; Bai S; Cleves MA; Xu HM; Lou XY
    Genet Epidemiol; 2019 Feb; 43(1):24-36. PubMed ID: 30387901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fuzzy-Based Multiobjective Multifactor Dimensionality Reduction for Epistasis Analysis.
    Yang CH; Huang HC; Hou MF; Chuang LY; Lin YD
    IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(1):378-387. PubMed ID: 35061588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epistasis, complexity, and multifactor dimensionality reduction.
    Pan Q; Hu T; Moore JH
    Methods Mol Biol; 2013; 1019():465-77. PubMed ID: 23756906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifactor dimensionality reduction reveals a strong gene-gene interaction between STC1 and COL11A1 genes as a possible risk factor of knee osteoarthritis.
    Fernández-Torres J; Martínez-Nava GA; Zamudio-Cuevas Y; Martínez-Flores K; Mijares-Díaz F
    Mol Biol Rep; 2020 Apr; 47(4):2627-2634. PubMed ID: 32140959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SVM-based generalized multifactor dimensionality reduction approaches for detecting gene-gene interactions in family studies.
    Fang YH; Chiu YF
    Genet Epidemiol; 2012 Feb; 36(2):88-98. PubMed ID: 22851472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.